Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.73M Buy
21,352
+244
+1% +$83.5K 2.19% 9
2026
Q1
$7.43M Buy
21,108
+235
+1% +$83.8K 2.28% 10
2025
Q4
$6.83M Buy
20,873
+281
+1% +$89.1K 2.09% 11
2025
Q3
$5.81M Buy
20,592
+167
+0.8% +$48.4K 1.79% 15
2025
Q2
$5.7M Buy
20,425
+2
+0% +$567 1.86% 15
2025
Q1
$6.36M Buy
20,423
+1,240
+6% +$366K 2.27% 8
2024
Q4
$5M Buy
19,183
+621
+3% +$184K 1.88% 15
2024
Q3
$5.98M Sell
18,562
-113
-0.6% -$37K 2.24% 8
2024
Q2
$5.84M Buy
18,675
+90
+0.5% +$26.4K 2.39% 7
2024
Q1
$5.28M Buy
18,585
+412
+2% +$121K 2.16% 6
2023
Q4
$5.23M Sell
18,173
-878
-5% -$239K 2.29% 7
2023
Q3
$5.12M Sell
19,051
-101
-0.5% -$25.2K 2.33% 7
2023
Q2
$4.25M Sell
19,152
-618
-3% -$143K 1.83% 17
2023
Q1
$4.78M Sell
19,770
-260
-1% -$63.8K 2.07% 11
2022
Q4
$5.26M Sell
20,030
-35
-0.2% -$9.38K 2.21% 8
2022
Q3
$4.52M Buy
20,065
+249
+1% +$60.4K 2.11% 8
2022
Q2
$4.82M Buy
19,816
+160
+0.8% +$39.2K 2.11% 8
2022
Q1
$4.75M Sell
19,656
-91
-0.5% -$20.9K 1.84% 15
2021
Q4
$4.44M Buy
19,747
+144
+0.7% +$30.4K 1.62% 20
2021
Q3
$4.17M Sell
19,603
-190
-1% -$43.7K 1.7% 14
2021
Q2
$4.82M Buy
19,793
+57
+0.3% +$14K 1.97% 12
2021
Q1
$4.91M Buy
19,736
+327
+2% +$78K 2.12% 11
2020
Q4
$4.46M Sell
19,409
-74
-0.4% -$17.1K 2.03% 11
2020
Q3
$4.95M Buy
19,483
+336
+2% +$83.2K 2.49% 8
2020
Q2
$4.52M Buy
19,147
+506
+3% +$115K 2.41% 9
2020
Q1
$3.78M Buy
18,641
+386
+2% +$84.3K 2.48% 8
2019
Q4
$4.4M Buy
18,255
+96
+0.5% +$21.2K 2.18% 10
2019
Q3
$3.51M Sell
18,159
-482
-3% -$92.5K 1.86% 12
2019
Q2
$3.44M Buy
18,641
+50
+0.3% +$8.95K 1.77% 12
2019
Q1
$3.53M Buy
18,591
+199
+1% +$38K 1.86% 12
2018
Q4
$3.58M Buy
18,392
+253
+1% +$49.4K 2.08% 10
2018
Q3
$3.76M Buy
18,139
+80
+0.4% +$15.8K 1.86% 10
2018
Q2
$3.33M Sell
18,059
-418
-2% -$73.9K 1.79% 11
2018
Q1
$3.15M Sell
18,477
-19
-0.1% -$3.49K 1.63% 12
2017
Q4
$3.22M Sell
18,496
-15
-0.1% -$2.65K 1.61% 13
2017
Q3
$3.45M Buy
18,511
+193
+1% +$34.2K 1.83% 11
2017
Q2
$3.15M Buy
18,318
+890
+5% +$145K 1.72% 12
2017
Q1
$2.86M Buy
17,428
+2,209
+15% +$367K 1.6% 10
2016
Q4
$2.23M Sell
15,219
-884
-5% -$133K 1.32% 19
2016
Q3
$2.69M Buy
16,103
+395
+3% +$66.8K 1.6% 12
2016
Q2
$2.39M Buy
15,708
+273
+2% +$42.4K 1.48% 14
2016
Q1
$2.31M Buy
15,435
+409
+3% +$60.8K 1.54% 11
2015
Q4
$2.44M Buy
15,026
+10,758
+252% +$1.69M 1.6% 10
2015
Q3
$590K Buy
4,268
+55
+1% +$8.67K 0.41% 98
2015
Q2
$646K Buy
+4,213
New +$675K 0.42% 97

Other funds holding AMGN

Somerset Trust's AMGN Position: Q2 2026 in Review

Somerset Trust increased its Amgen (AMGN) stake by 1.2% in Q2 2026, buying an estimated $83.5K and bringing the position to 21,352 shares worth $7.73M. The position accounts for 2.19% of the portfolio, ranked #9.

Somerset Trust first reported a position in AMGN in Q2 2015 and has held it in 45 quarters since. 1,262 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Somerset Trust held 21,352 shares of Amgen worth $7.73M as of Q2 2026.
  • Somerset Trust bought 244 Amgen shares in Q2 2026, an estimated $83.5K.
  • Amgen made up 2.19% of Somerset Trust's portfolio in Q2 2026, its #9 holding.
  • Somerset Trust first reported a position in Amgen in Q2 2015 and has held it in 45 quarters since.
  • 1,262 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Somerset Trust's 13F filing for Q2 2026, filed 6 Jul 2026.